Amphotericin B Liposomal Injection

Generic name: Pronounced as (am foe ter' I sin)
Brand names
  • AmBisome®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2016

Amphotericin B liposomal injection is used to treat fungal infections such as cryptococcal meningitis (a fungal infection of the lining of the spinal cord and brain) and visceral leishmaniasis (a parasitic disease that usually affects spleen, liver, and bone marrow) in certain people. It is also used to treat certain fungal infections in people who cannot receive conventional amphotericin B therapy. Amphotericin B liposomal injection is in a class of medications called antifungals. It works by slowing the growth of fungi that cause infection.

Amphotericin B liposomal injection comes as a suspension (liquid) to be injected intravenously (into a vein). It is usually infused intravenously once daily, or for the treatment of leishmaniasis on specific days, over a period of 2 hours. If previous doses are tolerated, this medication may be given over a period of 1 hour. The length of your treatment depends on your general health, how you tolerate the medication, and the type of infection you have.

You may experience a reaction while you receive a dose of amphotericin B liposomal complex injection. These reactions usually happen 1 to 3 hours after starting your infusion and are more severe with the first few doses. Your health care provider may prescribe other medications to decrease these side effects. Tell your doctor immediately if you experience any of these symptoms while you receive amphotericin B liposomal complex injection: fever, chills, nausea, vomiting, flushing, back pain with or without chest tightness, chest pain, shortness of breath, breathing problems, or a fast, irregular, or pounding heartbeat.

You may receive amphotericin B liposomal injection in a hospital or you may use the medication at home. If you will be using amphotericin B liposomal injection at home, your healthcare provider will show you how to infuse the medication. Be sure that you understand these directions, and ask your healthcare provider if you have any questions. Ask your healthcare provider what to do if you have any problems infusing amphotericin B liposomal injection.

If your symptoms do not improve or get worse while receiving amphotericin B liposomal injection, tell your doctor. If you still have symptoms of infection after you finish amphotericin B liposomal injection, tell your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving amphotericin B liposomal injection,

  • tell your doctor and pharmacist if you are allergic to amphotericin B, any other medications, or any of the ingredients in amphotericin B liposomal injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglycoside antibiotics such as amikacin, gentamicin, or tobramycin (Bethkis, Kitabis Pak, Tobi); antifungals such as clotrimazole, fluconazole (Diflucan), itraconazole (Onmel, Sporanox), ketoconazole (Extina, Nizoral, Xolegel), and miconazole (Oravig, Monistat); medications for the treatment of cancer; corticotropin (H.P. Acthar Gel); cyclosporine (Gengraf, Neoral, Sandimmune); digoxin (Lanoxin); flucytosine (Ancobon); and steroids taken orally such as dexamethasone, methylprednisolone (Medrol), and prednisone (Rayos). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you are receiving leukocyte (white blood cell) transfusions.

  • tell your doctor if you have or have ever had kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while receiving amphotericin B liposomal injection, call your doctor. Do not breast-feed while receiving amphotericin B liposomal injection.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving amphotericin B liposomal injection.

Unless your doctor tells you otherwise, continue your normal diet.

  • Amphotericin B liposomal injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • stomach pain

    • heartburn

    • diarrhea

    • constipation

    • loss of appetite

    • redness or swelling at the injection site

    • pale skin

    • shortness of breath

    • dizziness

    • headache

    • coldness in the hands and feet

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately or get emergency medical treatment:

    • rash

    • hives

    • difficulty breathing

    • itching

    • swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs

    • chest pain or tightness

    • black and tarry stools

    • decreased urination

    • blood in the urine

  • Amphotericin B liposomal injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests during your treatment to check your body's response to amphotericin B liposomal injection.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are receiving amphotericin B liposomal injection.

Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Amphotericin B.
Leflunomide Leflunomide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Leflunomide.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Amphotericin B.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Alendronic acid.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Amphotericin B.
Candesartan Candesartan Amphotericin B may increase the hypotensive activities of Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Amphotericin B.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate Amphotericin B may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Amphotericin B may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Amphotericin B may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate Mycophenolate Amphotericin B may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Amphotericin B.
Olsalazine Olsalazine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Olsalazine.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Amphotericin B.
Penbutolol Penbutolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Acebutolol.
Potassium Potassium Amphotericin B may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of hypokalemia can be increased when Prednisone is combined with Amphotericin B.
Ranitidine Ranitidine Amphotericin B may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine Amphotericin B may decrease the excretion rate of Reserpine which could result in a higher serum level.
Rizatriptan Rizatriptan Amphotericin B may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Amphotericin B may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Amphotericin B.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Etidronic acid.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Amphotericin B.
Triamcinolone Triamcinolone The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Amphotericin B.
Ampicillin Injection Ampicillin Injection Amphotericin B may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Amphotericin B may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Amphotericin B may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Amphotericin B may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Amphotericin B may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of hypokalemia can be increased when Methylprednisolone is combined with Amphotericin B.
Metoclopramide Injection Metoclopramide Injection Amphotericin B may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Amphotericin B.
Pamidronate Injection Pamidronate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Amphotericin B may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Amphotericin B.
Altretamine Altretamine Amphotericin B may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefuroxime.
Cyclosporine Cyclosporine Amphotericin B may increase the nephrotoxic activities of Cyclosporine.
Torsemide Torsemide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Torasemide.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Amphotericin B.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Amphotericin B.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Eprosartan.
Meloxicam Meloxicam The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Meloxicam.
Oxcarbazepine Oxcarbazepine The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Amphotericin B.
Pantoprazole Pantoprazole Amphotericin B may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Risedronic acid.
Telmisartan Telmisartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Telmisartan.
Temozolomide Temozolomide Amphotericin B may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Amphotericin B may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Linezolid Linezolid Linezolid may increase the orthostatic hypotensive activities of Amphotericin B.
Perindopril Perindopril Amphotericin B may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir Amphotericin B may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Choline magnesium trisalicylate.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Amphotericin B.
Eplerenone Eplerenone The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eplerenone.
Olmesartan Olmesartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Olmesartan.
Zonisamide Zonisamide Zonisamide may decrease the nephrotoxic activities of Amphotericin B.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Amphotericin B.
Atomoxetine Atomoxetine Amphotericin B may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Atazanavir Atazanavir The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Atazanavir.
Almotriptan Almotriptan Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Amphotericin B.
Rosuvastatin Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Amphotericin B.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Amphotericin B.
Emtricitabine Emtricitabine Amphotericin B may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Amphotericin B may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Amphotericin B may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Apomorphine.
Infliximab Injection Infliximab Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Amphotericin B.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Amphotericin B is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Amphotericin B.
Tinidazole Tinidazole Amphotericin B may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Amphotericin B may increase the hypotensive activities of Bosentan.
Cefditoren Cefditoren Amphotericin B may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Amphotericin B may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Amphotericin B.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Amphotericin B.
Ganciclovir Ganciclovir Amphotericin B may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Amphotericin B may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir Valganciclovir Amphotericin B may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Adefovir.
Dextroamphetamine Dextroamphetamine Amphotericin B may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amphotericin B is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Amphotericin B.
Ramelteon Ramelteon Amphotericin B may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Amphotericin B.
Pregabalin Pregabalin The therapeutic efficacy of Pregabalin can be decreased when used in combination with Amphotericin B.
Felbamate Felbamate The therapeutic efficacy of Felbamate can be decreased when used in combination with Amphotericin B.
Ranolazine Ranolazine Amphotericin B may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Rasagiline Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Amphotericin B.
Sitagliptin Sitagliptin Amphotericin B may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Amphotericin B may decrease the excretion rate of Varenicline which could result in a higher serum level.
Albuterol Albuterol Amphotericin B may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Amphotericin B may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Bortezomib Bortezomib The metabolism of Amphotericin B can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Amphotericin B may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Lubiprostone Lubiprostone Amphotericin B may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Posaconazole Posaconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Posaconazole.
Aliskiren Aliskiren The risk or severity of adverse effects can be increased when Amphotericin B is combined with Aliskiren.
Pemetrexed Injection Pemetrexed Injection Amphotericin B may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Amphotericin B.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Amphotericin B.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Amphotericin B.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Amphotericin B.
Levocetirizine Levocetirizine Amphotericin B may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Amphotericin B may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Amphotericin B.
Azacitidine Injection Azacitidine Injection Amphotericin B may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Amphotericin B.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Amphotericin B.
Lenalidomide Lenalidomide Amphotericin B may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Amphotericin B.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Raltegravir.
Budesonide Budesonide The risk or severity of hypokalemia can be increased when Budesonide is combined with Amphotericin B.
Desmopressin Desmopressin Amphotericin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Amphotericin B may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Amphotericin B may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Amphotericin B may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Amphotericin B may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Tretinoin.
Certolizumab Injection Certolizumab Injection Amphotericin B may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Amphotericin B.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Amphotericin B.
Daptomycin Injection Daptomycin Injection Amphotericin B may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Amphotericin B may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Amphotericin B.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Amphotericin B.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Amphotericin B may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Milnacipran Milnacipran Amphotericin B may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Amphotericin B may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Amphotericin B may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Betaxolol.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Amphotericin B.
Prasugrel Prasugrel Amphotericin B may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Amphotericin B.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Amphotericin B.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Amphotericin B.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Amphotericin B.
Pralatrexate Injection Pralatrexate Injection Amphotericin B may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Amphotericin B may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Amphotericin B may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Amphotericin B may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Amphotericin B.
Topotecan Topotecan Amphotericin B may decrease the excretion rate of Topotecan which could result in a higher serum level.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Amphotericin B.
Vigabatrin Vigabatrin The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Amphotericin B.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Pitavastatin.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Amphotericin B.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Amphotericin B is combined with Dalfampridine.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Amphotericin B.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Ceftaroline fosamil.
Acetaminophen Injection Acetaminophen Injection Amphotericin B may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Amphotericin B may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Amphotericin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Amphotericin B may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Amphotericin B.
Roflumilast Roflumilast Amphotericin B may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Amphotericin B.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Amphotericin B.
Rivaroxaban Rivaroxaban Amphotericin B may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Amphotericin B.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Amphotericin B.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Amphotericin B.
Clobazam Clobazam Amphotericin B may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be decreased when combined with Amphotericin B.
Deferiprone Deferiprone Amphotericin B may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Amphotericin B.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Amphotericin B.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Amphotericin B.
Naloxone Injection Naloxone Injection Amphotericin B may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan Amphotericin B may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Amphotericin B may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Ezogabine Ezogabine The therapeutic efficacy of Tiagabine can be decreased when used in combination with Amphotericin B.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Iloprost.
Enzalutamide Enzalutamide Amphotericin B may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Amphotericin B may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Amphotericin B.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Amphotericin B.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of hypokalemia can be increased when Corticotropin is combined with Amphotericin B.
Teduglutide Injection Teduglutide Injection Amphotericin B may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Amphotericin B.
Alogliptin Alogliptin Amphotericin B may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Amphotericin B.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Amphotericin B.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Amphotericin B.
Canagliflozin Canagliflozin Amphotericin B may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Methazolamide.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Amphotericin B.
Trametinib Trametinib Amphotericin B may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Amphotericin B may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Amphotericin B may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Amphotericin B may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel Perampanel The therapeutic efficacy of Perampanel can be decreased when used in combination with Amphotericin B.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Amphotericin B.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Amphotericin B.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Amphotericin B.
Ketorolac Injection Ketorolac Injection The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Amphotericin B.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Obinutuzumab.
Sofosbuvir Sofosbuvir Amphotericin B may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dapagliflozin.
Apremilast Apremilast Amphotericin B may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa Amphotericin B may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Amphotericin B.
Eslicarbazepine Eslicarbazepine The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Amphotericin B.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Amphotericin B.
Testosterone Injection Testosterone Injection Amphotericin B may decrease the excretion rate of Testosterone which could result in a higher serum level.
Empagliflozin Empagliflozin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Empagliflozin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Amphotericin B.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Amphotericin B.
Edoxaban Edoxaban Amphotericin B may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Amphotericin B.
Methamphetamine Methamphetamine Amphotericin B may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Amphotericin B may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat The risk or severity of adverse effects can be increased when Amphotericin B is combined with Riociguat.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Amphotericin B.
Risperidone Injection Risperidone Injection Amphotericin B may increase the hypotensive activities of Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Amphotericin B.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Amphotericin B.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Amphotericin B.
Amiloride Amiloride The risk or severity of adverse effects can be increased when Amiloride is combined with Amphotericin B.
Isavuconazonium Injection Isavuconazonium Injection The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Isavuconazonium.
Macitentan Macitentan Amphotericin B may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Amphotericin B.
Prednisolone Prednisolone The risk or severity of hypokalemia can be increased when Prednisolone is combined with Amphotericin B.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Amphotericin B.
Penicillin G Procaine Injection Penicillin G Procaine Injection Amphotericin B may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Amphotericin B.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Amphotericin B.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Amphotericin B.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Amphotericin B.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Amphotericin B.
Lesinurad Lesinurad Amphotericin B may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of hypokalemia can be increased when Dexamethasone is combined with Amphotericin B.
Brivaracetam Injection Brivaracetam Injection Amphotericin B may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Amphotericin B.
Selexipag Selexipag Amphotericin B may increase the hypotensive activities of Selexipag.
Furosemide Injection Furosemide Injection Amphotericin B may decrease the excretion rate of Furosemide which could result in a higher serum level.
Lixisenatide Injection Lixisenatide Injection Amphotericin B may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Amphotericin B.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Amphotericin B.
Doxepin (Insomnia) Doxepin (Insomnia) Amphotericin B may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Amphotericin B may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Amphotericin B may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of hypokalemia can be increased when Deflazacort is combined with Amphotericin B.
Safinamide Safinamide Safinamide may increase the orthostatic hypotensive activities of Amphotericin B.
Naldemedine Naldemedine Amphotericin B may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Midostaurin can be decreased when combined with Amphotericin B.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Amphotericin B.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Amphotericin B.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Amphotericin B.
Benznidazole Benznidazole Amphotericin B may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Amphotericin B.
Delafloxacin Delafloxacin Amphotericin B may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Amphotericin B.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Amphotericin B.
Apalutamide Apalutamide Amphotericin B may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Penicillamine.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Amphotericin B.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Amphotericin B.
Lofexidine Lofexidine Amphotericin B may decrease the excretion rate of Lofexidine which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Amphotericin B may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Amphotericin B.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Amphotericin B.
Cannabidiol Cannabidiol The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Amphotericin B.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Amphotericin B.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Amphotericin B.
Stiripentol Stiripentol Amphotericin B may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Amphotericin B.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Amphotericin B.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Amphotericin B.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Amphotericin B.
Acyclovir Ophthalmic Acyclovir Ophthalmic Amphotericin B may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Amphotericin B.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Amphotericin B.
Brexanolone Injection Brexanolone Injection The therapeutic efficacy of Brexanolone can be decreased when used in combination with Amphotericin B.
Cladribine Cladribine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Amphotericin B.
Solriamfetol Solriamfetol Amphotericin B may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Amphotericin B.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Amphotericin B.
Pitolisant Pitolisant Amphotericin B may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Lefamulin Lefamulin The metabolism of Lefamulin can be decreased when combined with Amphotericin B.
Phenytoin Injection Phenytoin Injection The therapeutic efficacy of Phenytoin can be decreased when used in combination with Amphotericin B.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Amphotericin B.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Amphotericin B.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Amphotericin B.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Amphotericin B.
Cenobamate Cenobamate The therapeutic efficacy of Cenobamate can be decreased when used in combination with Amphotericin B.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Amphotericin B.
Viloxazine Viloxazine Amphotericin B may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Amphotericin B may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Amphotericin B.
Fenoprofen Fenoprofen The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Amphotericin B.
Indomethacin Indomethacin The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Amphotericin B.
Mefenamic Acid Mefenamic Acid The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Mefenamic acid.
Naproxen Naproxen The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Naproxen.
Tolmetin Tolmetin The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Amphotericin B.
Sulindac Sulindac The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Amphotericin B.
Isotretinoin Isotretinoin Amphotericin B may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Amphotericin B may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine Amphotericin B may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Phenobarbital Phenobarbital Phenobarbital may increase the hypotensive activities of Amphotericin B.
Metaxalone Metaxalone Amphotericin B may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Amphotericin B.
Primidone Primidone Primidone may increase the hypotensive activities of Amphotericin B.
Methsuximide Methsuximide Methsuximide may decrease the nephrotoxic activities of Amphotericin B.
Chlorpromazine Chlorpromazine Amphotericin B may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Amphotericin B may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Amphotericin B may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Amphotericin B may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Amphotericin B may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Amphotericin B may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Phenoxybenzamine.
Carmustine Carmustine Amphotericin B may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Amphotericin B may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Amphotericin B may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Bromocriptine.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the orthostatic hypotensive activities of Amphotericin B.
Phenelzine Phenelzine Phenelzine may increase the orthostatic hypotensive activities of Amphotericin B.
Procarbazine Procarbazine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Procarbazine.
Tetracycline Tetracycline Amphotericin B may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Minocycline.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Amphotericin B.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Thioridazine is combined with Amphotericin B.
Bleomycin Bleomycin Amphotericin B may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Amphotericin B may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone Amphotericin B may decrease the excretion rate of Methadone which could result in a higher serum level.
Benztropine Benztropine Amphotericin B may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Maprotiline Maprotiline Amphotericin B may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen Amphotericin B may decrease the excretion rate of Ibuprofen which could result in a higher serum level.
Azathioprine Azathioprine Amphotericin B may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Amphotericin B.
Methylphenidate Methylphenidate Amphotericin B may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Sulfasalazine Sulfasalazine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Amphotericin B.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Amphotericin B.
Cytarabine Cytarabine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Cytarabine.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Phenazopyridine.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Amphotericin B.
Methyldopa Methyldopa Amphotericin B may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Amphotericin B.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Prazosin.
Hydralazine Hydralazine Amphotericin B may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Amphotericin B may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Amphotericin B may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Amphotericin B.
Clonazepam Clonazepam Amphotericin B may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide Loperamide may decrease the nephrotoxic activities of Amphotericin B.
Promethazine Promethazine Amphotericin B may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate Amphotericin B may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Amphotericin B may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Chloroquine Chloroquine Amphotericin B may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Ethosuximide Ethosuximide Ethosuximide may decrease the nephrotoxic activities of Amphotericin B.
Triamterene Triamterene The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Amphotericin B.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Amphotericin B.
Chlorothiazide Chlorothiazide The risk or severity of electrolyte imbalance can be increased when Amphotericin B is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Amphotericin B is combined with Chlorthalidone.
Metolazone Metolazone Amphotericin B may decrease the excretion rate of Metolazone which could result in a higher serum level.
Secobarbital Secobarbital Secobarbital may increase the hypotensive activities of Amphotericin B.
Desipramine Desipramine Amphotericin B may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amphotericin B may decrease the excretion rate of Amitriptyline which could result in a higher serum level.
Imipramine Imipramine Amphotericin B may decrease the excretion rate of Imipramine which could result in a higher serum level.
Probenecid Probenecid Amphotericin B may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Amphotericin B.
Procainamide Procainamide Amphotericin B may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Amphotericin B may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Amphotericin B may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Disopyramide Disopyramide Amphotericin B may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The therapeutic efficacy of Valproic acid can be decreased when used in combination with Amphotericin B.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Amphotericin B.
Butabarbital Butabarbital Amphotericin B may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Amphotericin B may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Amphotericin B may decrease the excretion rate of Methimazole which could result in a higher serum level.
Propylthiouracil Propylthiouracil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Amphotericin B.
Chlorpropamide Chlorpropamide Amphotericin B may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Tolbutamide Tolbutamide Amphotericin B may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Amphotericin B may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Amphotericin B.
Baclofen Baclofen Amphotericin B may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Amphotericin B may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of electrolyte imbalance can be increased when Methyclothiazide is combined with Amphotericin B.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of electrolyte imbalance can be increased when Amphotericin B is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone Amphotericin B may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Amphotericin B may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Amphotericin B may decrease the excretion rate of Folic acid which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level.
Minoxidil Minoxidil The risk or severity of adverse effects can be increased when Amphotericin B is combined with Minoxidil.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Amphotericin B.
Spironolactone Spironolactone The risk or severity of adverse effects can be increased when Spironolactone is combined with Amphotericin B.
Phytonadione Phytonadione Amphotericin B may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Amphotericin B which could result in a higher serum level.
Nadolol Nadolol Amphotericin B may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol Allopurinol Amphotericin B may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Amphotericin B may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Papaverine.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Amphotericin B.
Cefaclor Cefaclor Amphotericin B may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Amphotericin B may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefazolin.
Cephalexin Cephalexin Amphotericin B may decrease the excretion rate of Cephalexin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefoxitin.
Dacarbazine Dacarbazine Amphotericin B may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Amphotericin B.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Amphotericin B.
Calcitonin Salmon Injection Calcitonin Salmon Injection Amphotericin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Ketoconazole Ketoconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Ketoconazole.
Pyrantel Pyrantel Amphotericin B may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Amphotericin B.
Vincristine Injection Vincristine Injection The metabolism of Amphotericin B can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of adverse effects can be increased when Amphotericin B is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isoxsuprine.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Amphotericin B.
Ethacrynic Acid Ethacrynic Acid The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Etacrynic acid.
Colistimethate Injection Colistimethate Injection Amphotericin B may increase the nephrotoxic activities of Colistimethate.
Metoprolol Metoprolol Amphotericin B may decrease the excretion rate of Metoprolol which could result in a higher serum level.
Aspirin Aspirin The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Acetylsalicylic acid.
Salsalate Salsalate The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Salsalate.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Amphotericin B.
Temazepam Temazepam Amphotericin B may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Amphotericin B may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Amphotericin B may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Amphotericin B may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Amphotericin B may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem Diltiazem may decrease the nephrotoxic activities of Amphotericin B.
Nifedipine Nifedipine Nifedipine may decrease the nephrotoxic activities of Amphotericin B.
Timolol Timolol Amphotericin B may decrease the excretion rate of Timolol which could result in a higher serum level.
Verapamil Verapamil Verapamil may decrease the nephrotoxic activities of Amphotericin B.
Atenolol Atenolol The risk or severity of adverse effects can be increased when Amphotericin B is combined with Atenolol.
Pindolol Pindolol Amphotericin B may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Amphotericin B may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Amphotericin B may decrease the excretion rate of Diflunisal which could result in a higher serum level.
Piroxicam Piroxicam Amphotericin B may decrease the excretion rate of Piroxicam which could result in a higher serum level.
Bumetanide Bumetanide Amphotericin B may decrease the excretion rate of Bumetanide which could result in a higher serum level.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Amphotericin B.
Glipizide Glipizide Amphotericin B may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Amphotericin B may decrease the excretion rate of Indapamide which could result in a higher serum level.
Amoxicillin Amoxicillin Amphotericin B may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Amphotericin B may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Amphotericin B may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Amphotericin B may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol Amphotericin B may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Amphotericin B may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Amphotericin B may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil Amphotericin B may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz Amphotericin B may increase the hypotensive activities of Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Adefovir dipivoxil.
Ceftazidime Injection Ceftazidime Injection Amphotericin B may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
Ketoprofen Ketoprofen Amphotericin B may decrease the excretion rate of Ketoprofen which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Amphotericin B may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Amphotericin B.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Amphotericin B.
Flurbiprofen Flurbiprofen Amphotericin B may decrease the excretion rate of Flurbiprofen which could result in a higher serum level.
Amiodarone Amiodarone Amiodarone may decrease the nephrotoxic activities of Amphotericin B.
Aztreonam Injection Aztreonam Injection Amphotericin B may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Amphotericin B may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Amphotericin B.
Ciprofloxacin Ciprofloxacin Amphotericin B may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Amphotericin B.
Diclofenac Diclofenac The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Amphotericin B.
Nimodipine Nimodipine Nimodipine may decrease the nephrotoxic activities of Amphotericin B.
Clozapine Clozapine Clozapine may decrease the excretion rate of Amphotericin B which could result in a higher serum level.
Estazolam Estazolam Amphotericin B may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Ofloxacin.
Didanosine Didanosine Amphotericin B may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Amphotericin B may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Benazepril.
Etodolac Etodolac Amphotericin B may decrease the excretion rate of Etodolac which could result in a higher serum level.
Felodipine Felodipine Felodipine may decrease the nephrotoxic activities of Amphotericin B.
Fosinopril Fosinopril Amphotericin B may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Amphotericin B.
Pravastatin Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Amphotericin B.
Quinapril Quinapril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Quinapril.
Ramipril Ramipril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Ramipril.
Simvastatin Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Amphotericin B.
Amlodipine Amlodipine Amlodipine may decrease the nephrotoxic activities of Amphotericin B.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Amphotericin B.
Itraconazole Itraconazole The therapeutic efficacy of Amphotericin B can be decreased when used in combination with Itraconazole.
Lisinopril Lisinopril Amphotericin B may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin Amphotericin B may decrease the excretion rate of Oxaprozin which could result in a higher serum level.
Sotalol Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Amphotericin B.
Bisoprolol Bisoprolol Amphotericin B may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Amphotericin B.
Terazosin Terazosin The risk or severity of adverse effects can be increased when Amphotericin B is combined with Terazosin.
Isradipine Isradipine Isradipine may decrease the nephrotoxic activities of Amphotericin B.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Amphotericin B.
Gabapentin Gabapentin The therapeutic efficacy of Gabapentin can be decreased when used in combination with Amphotericin B.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Fluvastatin.
Venlafaxine Venlafaxine Amphotericin B may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Amphotericin B.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Amphotericin B.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Amphotericin B.
Fluvoxamine Fluvoxamine Amphotericin B may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
Nefazodone Nefazodone Amphotericin B may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine Lamotrigine may decrease the nephrotoxic activities of Amphotericin B.
Losartan Losartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Losartan.
Valacyclovir Valacyclovir Amphotericin B may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Amphotericin B.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Amphotericin B.
Carboplatin Injection Carboplatin Injection Amphotericin B may decrease the excretion rate of Carboplatin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Moexipril.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Amphotericin B.
Nicardipine Nicardipine Nicardipine may decrease the nephrotoxic activities of Amphotericin B.
Bupropion Bupropion The risk or severity of seizure can be increased when Amphotericin B is combined with Bupropion.
Ticlopidine Ticlopidine Amphotericin B may decrease the excretion rate of Ticlopidine which could result in a higher serum level.
Saquinavir Saquinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Saquinavir.
Metformin Metformin Amphotericin B may decrease the excretion rate of Metformin which could result in a higher serum level.
Nisoldipine Nisoldipine Nisoldipine may decrease the nephrotoxic activities of Amphotericin B.
Lamivudine Lamivudine Amphotericin B may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole The therapeutic efficacy of Riluzole can be decreased when used in combination with Amphotericin B.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Amifostine.
Acarbose Acarbose Amphotericin B may decrease the excretion rate of Acarbose which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Amphotericin B may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Amphotericin B.
Ritonavir Ritonavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Amphotericin B.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Amphotericin B.
Cidofovir Injection Cidofovir Injection Amphotericin B may decrease the excretion rate of Cidofovir which could result in a higher serum level.
Meropenem Injection Meropenem Injection Amphotericin B may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Amphotericin B.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Amphotericin B.
Fosfomycin Fosfomycin Amphotericin B may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Trandolapril Trandolapril The risk or severity of adverse effects can be increased when Amphotericin B is combined with Trandolapril.
Topiramate Topiramate Amphotericin B may decrease the excretion rate of Topiramate which could result in a higher serum level.
Valsartan Valsartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Valsartan.
Pramipexole Pramipexole Amphotericin B may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Amphotericin B.
Carvedilol Carvedilol Carvedilol may decrease the nephrotoxic activities of Amphotericin B.
Nilutamide Nilutamide Amphotericin B may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Amphotericin B may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline Selegiline may increase the orthostatic hypotensive activities of Amphotericin B.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Amphotericin B.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Letrozole.
Irbesartan Irbesartan The risk or severity of adverse effects can be increased when Amphotericin B is combined with Irbesartan.
Tamsulosin Tamsulosin Amphotericin B may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Amphotericin B.
Quetiapine Quetiapine Amphotericin B may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefpodoxime.
Cetirizine Cetirizine Amphotericin B may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Tolcapone Tolcapone Amphotericin B may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Capecitabine Capecitabine Amphotericin B may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Abacavir Abacavir Amphotericin B may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Amphotericin B.
Celecoxib Celecoxib The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Amphotericin B.
Rosiglitazone Rosiglitazone Amphotericin B may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine Amphotericin B may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Amphotericin B is combined with Thalidomide.
Oseltamivir Oseltamivir Amphotericin B may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Balsalazide Balsalazide The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Balsalazide.
Nateglinide Nateglinide Amphotericin B may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Levetiracetam Levetiracetam The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Amphotericin B.
Rabeprazole Rabeprazole Amphotericin B may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists